Business Context and Reporting Period
Company: Innovative Industrial Properties, Inc. (IIPR)
Filing Type: Form 8-K (Current Report)
Date of Report: August 9, 2019
Event: Entry into a material definitive agreement and completion of an asset acquisition involving a medical-use cannabis cultivation and processing facility in Scott Township, Pennsylvania.
Key Financial Metrics and Transaction Details
- Acquisition Cost: $942,000 (initial purchase price of the property).
- Total Expected Investment: Approximately $30.0 million (including up to $25.1 million in construction funding and up to $4.0 million in additional funding).
- Lease Term: Initial term expires November 8, 2034, with two options to extend for five-year periods each.
- Base Rent: $3,120,000 annualized, payable monthly. Rent is abated until November 9, 2019.
- Property Management Fee: 1.5% of the then-current Base Rent.
- Security Deposit: Initial cash deposit of $28,260.00; full deposit of $780,000 required within 18 months of lease commencement.
- Property Size: Approximately 31,000 square foot greenhouse and 23,000 square foot industrial facility.
Material Changes and Agreements
The Company, through its subsidiary IIP-PA 4 LLC, acquired the property from PharmaCann Penn Plant LLC (an affiliate of PharmaCann LLC) and entered into a triple-net lease. Key structural changes include:
- Development Agreement: The Tenant is responsible for developing the facility. The Landlord is obligated to reimburse development costs up to $25.1 million, with a potential increase of $4.0 million at the Tenant's election within the first nine months.
- Guaranty Structure: Tenant affiliates must provide a full guaranty. Additionally, a Multi-Party PA Agreement stipulates that upon the closing of the business combination between PharmaCann and MedMen Enterprises Inc., the surviving parent company (MedMen ParentCo) will execute a guaranty for the lease obligations.
- Repurchase Option: If the Tenant transfers required government approvals within the first four years, the Landlord may elect to require the Tenant to repurchase the property at the greater of its appraised value or a yield-based calculation (Base Rent divided by 9.75%), less unfunded construction costs.
Outlook, Risks, and Contingencies
- Forward-Looking Statements: The filing contains statements regarding the proposed transaction between PharmaCann and MedMen, which are subject to risks and uncertainties.
- Contingency on Merger: Specific lease provisions regarding the transfer of approvals and the automatic termination of certain clauses are contingent upon the Tenant becoming a majority-owned subsidiary of MedMen ParentCo.
- Construction Funding Conditions: The reimbursement of construction costs is subject to the satisfaction of certain conditions contained in the Development Agreement.
- Industry Risk: The property is intended for medical-use cannabis cultivation, an industry subject to evolving regulatory frameworks.
Investor Verification Checklist
- Verify the status of the business combination transaction between PharmaCann and MedMen Enterprises Inc. to confirm the guaranty obligations of MedMen ParentCo.
- Confirm the timeline for the completion of the greenhouse and industrial facility development to ensure rent commencement aligns with expectations.
- Review the specific conditions in the Development Agreement that must be satisfied for the Landlord to disburse the $25.1 million construction funding.
- Monitor the Tenant's ability to secure and maintain the required government approvals and licenses for cannabis operations.
- Assess the impact of the 9.75% yield cap on the potential repurchase price if the Tenant exercises the option to transfer approvals.